Pharmacosmos launches cell therapy market offensive

After launching a new product for freezing down for example stem cells, Pharmacosmos aims to become a leading supplier for the growing number of companies working with cell therapy.

Photo: Pharmacosmos / PR

Usually, all eyes are on the Pharmacosmos business leg which develops treatments for people - for example, those suffering from anemia.

Now, however, one of its other business legs is taking a big step forward, as the company has launched a product targeting cells, which will make it a serious player in the cell therapy area.

Read the whole article

Get 14 days free access.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Pfizer upgrades guidance for sales of covid-19 vaccine

The US pharmaceutical company Pfizer now predicts sales of its coronavirus vaccines will total USD 33.5bn this year. The previous estimate was UDS 26bn. Meanwhile, the company has revealed the guidance for its annual revenue.

Further reading

Related articles

Trial banner

Latest news

See all jobs